Logo image of CVNA

CARVANA CO (CVNA) Stock Fundamental Analysis

NYSE:CVNA - New York Stock Exchange, Inc. - US1468691027 - Common Stock - Currency: USD

319.89  +11.98 (+3.89%)

After market: 319.51 -0.38 (-0.12%)

Fundamental Rating

5

CVNA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. CVNA has an excellent financial health rating, but there are some minor concerns on its profitability. CVNA is valued quite expensively, but it does show have an excellent growth rating. With these ratings, CVNA could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CVNA had positive earnings in the past year.
In the past year CVNA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CVNA reported negative net income in multiple years.
In multiple years CVNA reported negative operating cash flow during the last 5 years.
CVNA Yearly Net Income VS EBIT VS OCF VS FCFCVNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

CVNA has a better Return On Assets (4.48%) than 66.12% of its industry peers.
With an excellent Return On Equity value of 26.46%, CVNA belongs to the best of the industry, outperforming 82.64% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 14.11%, CVNA belongs to the top of the industry, outperforming 82.64% of the companies in the same industry.
Industry RankSector Rank
ROA 4.48%
ROE 26.46%
ROIC 14.11%
ROA(3y)-3.14%
ROA(5y)-3.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CVNA Yearly ROA, ROE, ROICCVNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

The Profit Margin of CVNA (2.68%) is better than 65.29% of its industry peers.
The Operating Margin of CVNA (8.42%) is better than 80.17% of its industry peers.
The Gross Margin of CVNA (21.65%) is worse than 80.17% of its industry peers.
CVNA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.42%
PM (TTM) 2.68%
GM 21.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.8%
GM growth 5Y10.37%
CVNA Yearly Profit, Operating, Gross MarginsCVNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

7

2. Health

2.1 Basic Checks

CVNA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CVNA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CVNA has more shares outstanding
The debt/assets ratio for CVNA has been reduced compared to a year ago.
CVNA Yearly Shares OutstandingCVNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CVNA Yearly Total Debt VS Total AssetsCVNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CVNA has an Altman-Z score of 7.82. This indicates that CVNA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.82, CVNA belongs to the top of the industry, outperforming 98.35% of the companies in the same industry.
The Debt to FCF ratio of CVNA is 5.94, which is a neutral value as it means it would take CVNA, 5.94 years of fcf income to pay off all of its debts.
CVNA has a Debt to FCF ratio of 5.94. This is in the better half of the industry: CVNA outperforms 60.33% of its industry peers.
A Debt/Equity ratio of 3.55 is on the high side and indicates that CVNA has dependencies on debt financing.
The Debt to Equity ratio of CVNA (3.55) is worse than 77.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF 5.94
Altman-Z 7.82
ROIC/WACC1.53
WACC9.21%
CVNA Yearly LT Debt VS Equity VS FCFCVNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

CVNA has a Current Ratio of 3.81. This indicates that CVNA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.81, CVNA belongs to the best of the industry, outperforming 95.04% of the companies in the same industry.
A Quick Ratio of 2.70 indicates that CVNA has no problem at all paying its short term obligations.
CVNA has a better Quick ratio (2.70) than 96.69% of its industry peers.
Industry RankSector Rank
Current Ratio 3.81
Quick Ratio 2.7
CVNA Yearly Current Assets VS Current LiabilitesCVNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

7

3. Growth

3.1 Past

CVNA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 260.11%, which is quite impressive.
CVNA shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.23%.
The Revenue has been growing by 28.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)260.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%556.52%
Revenue 1Y (TTM)32.23%
Revenue growth 3Y2.19%
Revenue growth 5Y28.25%
Sales Q2Q%38.26%

3.2 Future

CVNA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.89% yearly.
Based on estimates for the next years, CVNA will show a quite strong growth in Revenue. The Revenue will grow by 18.05% on average per year.
EPS Next Y194.05%
EPS Next 2Y94.58%
EPS Next 3Y64.43%
EPS Next 5Y42.89%
Revenue Next Year32.03%
Revenue Next 2Y26.87%
Revenue Next 3Y25.21%
Revenue Next 5Y18.06%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CVNA Yearly Revenue VS EstimatesCVNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B
CVNA Yearly EPS VS EstimatesCVNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 10 -10

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 112.24, CVNA can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CVNA is on the same level as its industry peers.
CVNA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.35.
With a Price/Forward Earnings ratio of 53.82, CVNA can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CVNA indicates a slightly more expensive valuation: CVNA is more expensive than 65.29% of the companies listed in the same industry.
CVNA is valuated expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 112.24
Fwd PE 53.82
CVNA Price Earnings VS Forward Price EarningsCVNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CVNA indicates a slightly more expensive valuation: CVNA is more expensive than 65.29% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as CVNA.
Industry RankSector Rank
P/FCF 72.18
EV/EBITDA 45.05
CVNA Per share dataCVNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CVNA's earnings are expected to grow with 64.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y94.58%
EPS Next 3Y64.43%

0

5. Dividend

5.1 Amount

CVNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CARVANA CO

NYSE:CVNA (6/20/2025, 8:27:40 PM)

After market: 319.51 -0.38 (-0.12%)

319.89

+11.98 (+3.89%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners91.99%
Inst Owner Change-1.21%
Ins Owners2.83%
Ins Owner Change-0.68%
Market Cap68.50B
Analysts77.78
Price Target293.07 (-8.38%)
Short Float %7.28%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)110.73%
Min EPS beat(2)90.71%
Max EPS beat(2)130.76%
EPS beat(4)4
Avg EPS beat(4)169.37%
Min EPS beat(4)90.71%
Max EPS beat(4)305.93%
EPS beat(8)7
Avg EPS beat(8)111.76%
EPS beat(12)9
Avg EPS beat(12)81.47%
EPS beat(16)10
Avg EPS beat(16)62.17%
Revenue beat(2)2
Avg Revenue beat(2)4.59%
Min Revenue beat(2)4.24%
Max Revenue beat(2)4.94%
Revenue beat(4)4
Avg Revenue beat(4)4.01%
Min Revenue beat(4)3.05%
Max Revenue beat(4)4.94%
Revenue beat(8)6
Avg Revenue beat(8)4.07%
Revenue beat(12)6
Avg Revenue beat(12)0.45%
Revenue beat(16)10
Avg Revenue beat(16)3%
PT rev (1m)12.07%
PT rev (3m)9.45%
EPS NQ rev (1m)1.15%
EPS NQ rev (3m)37.05%
EPS NY rev (1m)0%
EPS NY rev (3m)98.05%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)9.25%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)7.46%
Valuation
Industry RankSector Rank
PE 112.24
Fwd PE 53.82
P/S 4.61
P/FCF 72.18
P/OCF 65.3
P/B 45.55
P/tB 46.69
EV/EBITDA 45.05
EPS(TTM)2.85
EY0.89%
EPS(NY)5.94
Fwd EY1.86%
FCF(TTM)4.43
FCFY1.39%
OCF(TTM)4.9
OCFY1.53%
SpS69.32
BVpS7.02
TBVpS6.85
PEG (NY)0.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.48%
ROE 26.46%
ROCE 16.6%
ROIC 14.11%
ROICexc 18.68%
ROICexgc 18.8%
OM 8.42%
PM (TTM) 2.68%
GM 21.65%
FCFM 6.39%
ROA(3y)-3.14%
ROA(5y)-3.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.8%
GM growth 5Y10.37%
F-Score7
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF 5.94
Debt/EBITDA 3.45
Cap/Depr 33.78%
Cap/Sales 0.67%
Interest Coverage 5.53
Cash Conversion 67.85%
Profit Quality 238.44%
Current Ratio 3.81
Quick Ratio 2.7
Altman-Z 7.82
F-Score7
WACC9.21%
ROIC/WACC1.53
Cap/Depr(3y)83.57%
Cap/Depr(5y)253.76%
Cap/Sales(3y)1.75%
Cap/Sales(5y)3.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%556.52%
EPS Next Y194.05%
EPS Next 2Y94.58%
EPS Next 3Y64.43%
EPS Next 5Y42.89%
Revenue 1Y (TTM)32.23%
Revenue growth 3Y2.19%
Revenue growth 5Y28.25%
Sales Q2Q%38.26%
Revenue Next Year32.03%
Revenue Next 2Y26.87%
Revenue Next 3Y25.21%
Revenue Next 5Y18.06%
EBIT growth 1Y551.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.74%
EBIT Next 3Y48%
EBIT Next 5Y32.3%
FCF growth 1Y184.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y231.62%
OCF growth 3YN/A
OCF growth 5YN/A